Fresenius SE Operating Margin 2016-2024 | FSNUY

Current and historical operating margin for Fresenius SE (FSNUY) over the last 10 years. The current operating profit margin for Fresenius SE as of September 30, 2024 is 8.19%.
Fresenius SE Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-09-30 $13.83B $0.86B 6.19%
2024-06-30 $13.94B $0.69B 4.97%
2024-03-31 $19.35B $1.00B 5.17%
2023-12-31 $24.13B $1.24B 5.13%
2023-09-30 $39.20B $2.51B 6.40%
2023-06-30 $43.73B $3.02B 6.92%
2023-03-31 $43.10B $3.33B 7.73%
2022-12-31 $43.03B $3.50B 8.13%
2022-09-30 $43.53B $4.09B 9.40%
2022-06-30 $43.99B $4.39B 9.98%
2022-03-31 $44.47B $4.72B 10.61%
2021-12-31 $44.39B $4.92B 11.08%
2021-09-30 $44.08B $4.86B 11.03%
2021-06-30 $43.51B $4.97B 11.43%
2021-03-31 $42.19B $4.98B 11.81%
2020-12-31 $41.44B $5.01B 12.09%
2020-09-30 $40.66B $5.19B 12.76%
2020-06-30 $40.06B $5.14B 12.83%
2020-03-31 $40.09B $5.16B 12.87%
2019-12-31 $39.66B $5.19B 13.08%
2019-09-30 $39.42B $5.18B 13.13%
2019-06-30 $39.12B $5.13B 13.12%
2019-03-31 $39.27B $6.19B 15.77%
2018-12-31 $39.60B $6.20B 15.66%
2018-09-30 $39.76B $6.10B 15.34%
2018-06-30 $39.98B $6.20B 15.50%
2018-03-31 $39.37B $5.16B 13.12%
2017-12-31 $38.30B $5.19B 13.54%
2017-09-30 $36.47B $5.24B 14.35%
2017-06-30 $34.84B $5.12B 14.70%
2017-03-31 $33.47B $5.03B 15.02%
2016-12-31 $32.18B $4.79B 14.88%
2016-09-30 $31.71B $11.39B 35.93%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $23.628B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.755B 19.47
Encompass Health (EHC) United States $11.734B 24.87
DaVita (DVA) United States $11.050B 14.67
Chemed (CHE) United States $8.342B 26.22
Elanco Animal Health (ELAN) United States $5.940B 12.72
Option Care Health (OPCH) United States $5.214B 23.24
RadNet (RDNT) United States $4.181B 88.48
Amedisys (AMED) United States $3.128B 21.04
LifeStance Health (LFST) United States $2.228B 0.00
Addus HomeCare (ADUS) United States $2.041B 22.41
Astrana Health (ASTH) United States $1.666B 41.26
U.S Physical Therapy (USPH) United States $1.125B 29.05
Aveanna Healthcare Holdings (AVAH) United States $1.054B 60.00
Pennant (PNTG) United States $0.985B 36.18
Atai Life Sciences (ATAI) Germany $0.278B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00